The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Kymera Therapeutics Inc (NASDAQ: KYMR) was $42.63 for the day, up 2.60% from the previous closing price of $41.55. In other words, the price has increased by $2.60 from its previous closing price. On the day, 0.82 million shares were traded. KYMR stock price reached its highest trading level at $42.66 during the session, while it also had its lowest trading level at $41.7.
Ratios:
Our analysis of KYMR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.32 and its Current Ratio is at 8.32. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
Morgan Stanley Upgraded its Equal-Weight to Overweight on June 03, 2025, while the target price for the stock was maintained at $79.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 30 ’25 when BVF PARTNERS L P/IL bought 317,167 shares for $44.00 per share. The transaction valued at 13,955,348 led to the insider holds 2,798,795 shares of the business.
BAKER BROS. ADVISORS LP bought 655,500 shares of KYMR for $28,842,000 on Jun 30 ’25. The Director now owns 6,117,295 shares after completing the transaction at $44.00 per share. On Jun 11 ’25, another insider, Ridloff Elena, who serves as the Director of the company, sold 4,500 shares for $50.00 each. As a result, the insider received 225,000 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 3047942656 and an Enterprise Value of 2468211456. For the stock, the TTM Price-to-Sale (P/S) ratio is 68.17 while its Price-to-Book (P/B) ratio in mrq is 3.10. Its current Enterprise Value per Revenue stands at 55.204 whereas that against EBITDA is -8.091.
Stock Price History:
The Beta on a monthly basis for KYMR is 2.18, which has changed by -0.043097615 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $19.44. The 50-Day Moving Average of the stock is -4.67%, while the 200-Day Moving Average is calculated to be 9.48%.
Shares Statistics:
KYMR traded an average of 877.73K shares per day over the past three months and 776230 shares per day over the past ten days. A total of 70.56M shares are outstanding, with a floating share count of 59.18M. Insiders hold about 16.95% of the company’s shares, while institutions hold 94.96% stake in the company. Shares short for KYMR as of 1753920000 were 7754994 with a Short Ratio of 8.84, compared to 1751241600 on 8035160. Therefore, it implies a Short% of Shares Outstanding of 7754994 and a Short% of Float of 13.700000000000001.
